FASN Human Pre-designed siRNA Set A contains three designed siRNAs for FASN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fasn Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fasn gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fasn Rat Pre-designed siRNA Set A contains three designed siRNAs for Fasn gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fast green FCF free acid is a dye that is acid-resistant.

Fast Red TR (napadisylate) is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes […]

FASTK Human Pre-designed siRNA Set A contains three designed siRNAs for FASTK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FASTKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FASTKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FASTKD2 Human Pre-designed siRNA Set A contains three designed siRNAs for FASTKD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FASTKD5 Human Pre-designed siRNA Set A contains three designed siRNAs for FASTKD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for FAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FAT2 Human Pre-designed siRNA Set A contains three designed siRNAs for FAT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FAT3 Human Pre-designed siRNA Set A contains three designed siRNAs for FAT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FAT4 Human Pre-designed siRNA Set A contains three designed siRNAs for FAT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FATE1 Human Pre-designed siRNA Set A contains three designed siRNAs for FATE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fatty acids (FAs) are the main components of lipids. The synthesis of fatty acids mainly involves the Triglyceride (TG) cycle and De Novo Lipogenesis (DNL). Fatty acids which exist widely in organisms are components of cell membranes and play an indispensable role in cell signaling. In addition, FFAs can be taken up from circulating plasma […]

FAU Human Pre-designed siRNA Set A contains three designed siRNAs for FAU gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FaX-IN-1 (compound 11A) is an intermediate in the preparation of FaX inhibitors and was used to study the inhibitory activity against venous thrombosis in rats[1].

FaX-IN-1 (compound 11A) is an intermediate in the preparation of FaX inhibitors and was used to study the inhibitory activity against venous thrombosis in rats[1].

FaX-IN-1 (compound 11A) is an intermediate in the preparation of FaX inhibitors and was used to study the inhibitory activity against venous thrombosis in rats[1].

FaX-IN-1 (compound 11A) is an intermediate in the preparation of FaX inhibitors and was used to study the inhibitory activity against venous thrombosis in rats[1].

FaX-IN-1 (compound 11A) is an intermediate in the preparation of FaX inhibitors and was used to study the inhibitory activity against venous thrombosis in rats[1].

FAXC Human Pre-designed siRNA Set A contains three designed siRNAs for FAXC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FAZ-3532 (compound G3Ia) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.54 μM. FAZ-3532 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

FAZ-3532 (compound G3Ia) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.54 μM. FAZ-3532 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

FAZ-3532 (compound G3Ia) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.54 μM. FAZ-3532 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

FAZ-3532 (compound G3Ia) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.54 μM. FAZ-3532 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

FAZ-3532 (compound G3Ia) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.54 μM. FAZ-3532 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

FAZ-3780 (compound G3Ib) is an inhibitor of binding to the NTF2L domain of G3BP1/2 that binds to G3BP1 with a Kd of 0.15 μM. FAZ-3780 targets the protein-protein interaction domain of G3BP1/2 and specifically inhibits co-condensation of G3BP1, caprin 1, and RNA in vitro[1].

Fazirsiran sodium is a second-generation RNAi agent. Fazirsiran sodium consistes of a cholesterol-conjugated RNAi trigger (chol-RNAi) to selectively degrade Alpha1-antitrypsin (AAT) mRNA by RNAi and a melittin-derived peptide conjugated to N-acetylgalactosamine (NAG) formulated as the excipient EX1 to promote endosomal escape of the chol-RNAi in hepatocytes[1]. Fazirsiran sodium can be used in the study of […]

Fazirsiran sodium is a second-generation RNAi agent. Fazirsiran sodium consistes of a cholesterol-conjugated RNAi trigger (chol-RNAi) to selectively degrade Alpha1-antitrypsin (AAT) mRNA by RNAi and a melittin-derived peptide conjugated to N-acetylgalactosamine (NAG) formulated as the excipient EX1 to promote endosomal escape of the chol-RNAi in hepatocytes[1]. Fazirsiran sodium can be used in the study of […]

Fazirsiran sodium is a second-generation RNAi agent. Fazirsiran sodium consistes of a cholesterol-conjugated RNAi trigger (chol-RNAi) to selectively degrade Alpha1-antitrypsin (AAT) mRNA by RNAi and a melittin-derived peptide conjugated to N-acetylgalactosamine (NAG) formulated as the excipient EX1 to promote endosomal escape of the chol-RNAi in hepatocytes[1]. Fazirsiran sodium can be used in the study of […]

FBF1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBH1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBL Human Pre-designed siRNA Set A contains three designed siRNAs for FBL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLIM1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLIM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLL1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLN1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLN2 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLN5 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBLN7 Human Pre-designed siRNA Set A contains three designed siRNAs for FBLN7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBN1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBN2 Human Pre-designed siRNA Set A contains three designed siRNAs for FBN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBN3 Human Pre-designed siRNA Set A contains three designed siRNAs for FBN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for FBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBRS Human Pre-designed siRNA Set A contains three designed siRNAs for FBRS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBRSL1 Human Pre-designed siRNA Set A contains three designed siRNAs for FBRSL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBXL12 Human Pre-designed siRNA Set A contains three designed siRNAs for FBXL12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FBXL14 Human Pre-designed siRNA Set A contains three designed siRNAs for FBXL14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.